Share on StockTwits

CorMedix IncStock (NASDAQ:CRMD) CEO Randy Milby purchased 2,732 shares of CorMedix IncStock stock on the open market in a transaction dated Monday, June 30th. The shares were purchased at an average cost of $1.83 per share, for a total transaction of $4,999.56. Following the purchase, the chief executive officer now directly owns 2,732 shares of the company’s stock, valued at approximately $5,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

CorMedix IncStock (NASDAQ:CRMD) opened at 1.86 on Friday. CorMedix IncStock has a 52-week low of $0.66 and a 52-week high of $3.20. The stock has a 50-day moving average of $1.56 and a 200-day moving average of $1.9. The company’s market cap is $35.8 million.

CorMedix Inc (NASDAQ:CRMD) is a biopharmaceutical company that focuses on in-licensing, developing and commercializing therapeutic products for the treatment of cardiac and renal dysfunction, also know as Cardiorenal disease.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.